Jessica Collinson, NP
Acute Care · Cranston, RINPI 1538752597
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,899 of the $4,526 with a category attached, or 86.1%. It is spread thinly across 28 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,376, 3.9 times the $864 reported in 2022. Among acute care clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 177 payments — averaging $25.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$862
- Arthrex$596
- EMD Serono, Inc.$306
- SK Life Science, Inc.$281
- Kairos Surgical Inc$267
- UCB, Inc.$267
- plus $2K from 22 others
What the payments were for
- Travel & lodging$56913%
- Food & beverage$3,89986%
- Education$581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $862 |
| Arthrex | 13 | $596 |
| EMD Serono, Inc. | 14 | $306 |
| SK Life Science, Inc. | 15 | $281 |
| Kairos Surgical Inc | 3 | $267 |
| UCB, Inc. | 9 | $267 |
| Pfizer | 13 | $221 |
| Neurelis, Inc. | 9 | $207 |
| Lundbeck LLC | 8 | $178 |
| Teva Pharmaceuticals USA, Inc. | 5 | $148 |
| Lilly USA, LLC | 6 | $129 |
| Amgen | 5 | $112 |
| Genentech USA, Inc. | 5 | $110 |
| Axsome Therapeutics, Inc. | 3 | $105 |
| Vanda Pharmaceuticals Inc. | 4 | $96 |
| Catalyst Pharmaceuticals, Inc. | 4 | $94 |
| Biogen | 4 | $90 |
| CSL Behring | 3 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| Novartis | 2 | $62 |
| Mallinckrodt Hospital Products Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Neurocrine Biosciences, Inc. | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| TG Therapeutics, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $20 |
| Sanofi | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,526 in reported general payments places this provider in the 90th percentile of 66 acute care providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 100 | $823 |
| Oxycodone Hcl | 82 | $349 |
| Meloxicam | 36 | $116 |
| Naproxen | 23 | $108 |
| Prednisone | 13 | $74 |
| Mupirocin | 13 | $71 |
| Tramadol Hcl | 38 | $49 |
| Amoxicillin | 20 | $44 |
Paid to pharmacies, not to this prescriber.
Other acute care in Cranston
- Beth DufourCranston$244
- Miranda WingCranston$206
- Renee BernardProvidence$21K
- Dale SumilangProvidence$10K
- Colleen PlanchonProvidence$5K
- Nicole CampbellProvidence$5K
- David GardnerProvidence$5K
- Allison TaskinLincoln$3K
- Keith ChamberlandNorth Providence$2K
- Kathryn ArnerProvidence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.